Is Edema Zone Volume Associated With Ki-67 Index in Glioblastoma Patients?
暂无分享,去创建一个
W. Tognola | R. Caramanti | D. Morais | M. Góes | F. Chaddad-Neto | R. Aprígio | Carlos E D`Aglio Rocha
[1] P. Lambin,et al. Prognostic and Predictive Value of Integrated Qualitative and Quantitative Magnetic Resonance Imaging Analysis in Glioblastoma , 2021, Cancers.
[2] A. Frati,et al. Is Ki-67 index overexpression in IDH wild type glioblastoma a predictor of shorter Progression Free survival? A clinical and Molecular analytic investigation , 2020, Clinical Neurology and Neurosurgery.
[3] Jia Fu,et al. Prognostic factors of patients with Gliomas – an analysis on 335 patients with Glioblastoma and other forms of Gliomas , 2020, BMC Cancer.
[4] Leland S. Hu,et al. Assessment of Prognostic Value of Cystic Features in Glioblastoma Relative to Sex and Treatment With Standard-of-Care , 2019, Frontiers in Oncology.
[5] A. Erbersdobler,et al. Correlation of Ki-67 Index with Volumetric Segmentation and its Value as a Prognostic Marker in Glioblastoma. , 2019, World neurosurgery.
[6] V. Gebski,et al. Cut‐point for Ki‐67 proliferation index as a prognostic marker for glioblastoma , 2019, Asia-Pacific journal of clinical oncology.
[7] M. Korja,et al. Glioblastoma survival is improving despite increasing incidence rates: a nationwide study between 2000 and 2013 in Finland , 2018, Neuro-oncology.
[8] J. Barnholtz-Sloan,et al. CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2012-2016. , 2019, Neuro-oncology.
[9] Mohammed A. Alharbi,et al. Ki-67 labeling index in glioblastoma; does it really matter? , 2019, Hematology/oncology and stem cell therapy.
[10] Tomasz Tykocki,et al. Ten-year survival in glioblastoma. A systematic review , 2018, Journal of Clinical Neuroscience.
[11] M. Paknahad,et al. Cancers of the Brain and CNS: Global Patterns and Trends in Incidence , 2018, Journal of biomedical physics & engineering.
[12] J. Piek,et al. Volumetric quantification of glioblastoma: experiences with different measurement techniques and impact on survival , 2017, Journal of Neuro-Oncology.
[13] F. Bray,et al. Cancers of the brain and CNS: global patterns and trends in incidence , 2016, Neuro-oncology.
[14] Dima Suki,et al. Association of the Extent of Resection With Survival in Glioblastoma: A Systematic Review and Meta-analysis. , 2016, JAMA oncology.
[15] Anthony A. Hyman,et al. Ki-67 acts as a biological surfactant to disperse mitotic chromosomes , 2016, Nature.
[16] K. Fürst,et al. Effect of 10 different polymorphisms on preoperative volumetric characteristics of glioblastoma multiforme , 2016, Journal of Neuro-Oncology.
[17] Atle Bjørnerud,et al. Volumetric glioma quantification: comparison of manual and semi-automatic tumor segmentation for the quantification of tumor growth , 2015, Acta radiologica.
[18] F. Ren,et al. Ki-67 is a valuable prognostic factor in gliomas: evidence from a systematic review and meta-analysis. , 2015, Asian Pacific journal of cancer prevention : APJCP.
[19] Andrejs Vanags,et al. Heterogeneity of Ki-67 and p53 Expression in Glioblastoma , 2014 .
[20] Y. Dang,et al. Effects of miR-152 on cell growth inhibition, motility suppression and apoptosis induction in hepatocellular carcinoma cells. , 2014, Asian Pacific journal of cancer prevention : APJCP.
[21] J. Barnholtz-Sloan,et al. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007-2011. , 2012, Neuro-oncology.
[22] Ferenc A. Jolesz,et al. Radiogenomic Mapping of Edema/Cellular Invasion MRI-Phenotypes in Glioblastoma Multiforme , 2011, PloS one.
[23] Bruce Shadbolt,et al. A multicenter study of primary brain tumor incidence in Australia (2000-2008). , 2011, Neuro-oncology.
[24] H. Mehdorn,et al. Outcome evaluation in glioblastoma patients using different ranking scores: KPS, GOS, mRS and MRC. , 2010, European journal of cancer care.
[25] Martin J. van den Bent,et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. , 2005, The New England journal of medicine.
[26] Z L Gokaslan,et al. A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. , 2001, Journal of neurosurgery.
[27] H. Shimizu,et al. Correlation between choline level measured by proton MR spectroscopy and Ki-67 labeling index in gliomas. , 2000, AJNR. American journal of neuroradiology.